The PTPN22 locus and rheumatoid arthritis: No evidence for an effect on risk independent of Arg620Trp

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Wan Taib, Wan R ^a   Smyth, Deborah J ^b   Merriman, Marilyn E ^a   Dalbeth, Nicola ^c   Gow, Peter J ^d   Harrison, Andrew A ^a   Highton, John ^a   Jones, Peter B B ^c   Stamp, Lisa ^e   Steer, Sophia ^f   Todd, John A ^b   Merriman, Tony R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d MIDDLEMORE HOSPITAL   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; B CELL LYMPHOMA 2 FAMILY KIN PROTEIN; GENE PRODUCT; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN BFK; TRYPTOPHAN; UNCLASSIFIED DRUG; PTPN22 PROTEIN, HUMAN;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NEW ZEALAND; RHEUMATOID ARTHRITIS; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; GENETIC PREDISPOSITION; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ARTHRITIS, RHEUMATOID; BASE SEQUENCE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK FACTORS;

EID: 78149443358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013544     Document Type: Article

References (21)

1. Steer S, Abkevich V, Gutin A, Cordell HJ, Gendall KL, et al. (2007) Genomic DNA pooling for whole genome association scans in complex disease: Empirical demonstration of efficacy in rheumatoid arthritis. Genes Immun 8: 57-68.
2. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
3. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 357: 1199-1209.
4. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, et al. (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology 46: 49-56.
5. Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, et al. (2006) Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 40: 586-593.
6. Wu J, Katrekar A, Honigberg LA, Smith AM, Conn MT, et al. (2006) Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem 281: 11002-11010.
7. Vang T, Congia M, Macis MD, Musumeci L, Orrú V, et al. (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37: 1317-1319.
8. Arechiga AF, Habib T, He Y, Zhand X, Zhang Z-Y, et al. (2009) The PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 182: 3343-3347.
9. Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC (2005) PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 77: 567-581.
10. Hinks A, Eyre S, Barton A, Thomson W, Worthington J (2007) Investigation of genetic variation across the protein tyrosine phosphatase gene in patients with rheumatoid arthritis in the UK. Ann Rheum Dis 66: 683-686.
11. Wesoly J, Hu X, Thabet MM, Chang M, Uh H, et al. (2007) The Trp620 allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population. Rheumatology (Oxford) 46: 617-621.
12. Viken MK, Olsson M, Flam ST, Forre O, Kvien TK, et al. (2007) The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens 70: 190-197.
13. Smyth DJ, Cooper JD, Howson JM, Walker NM, Plagnol V, et al. (2008) PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetesand shows a statistical interaction with HLA class II genotypes. Diabetes 57: 1730-1737.
14. Orrú V, Tsai SJ, Rueda B, Fiorillo E, Stanford SM, et al. (2009) A loss-of- function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 18: 569-579.
15. Rodrígeuz-Rodrígeuz L, Wan Taib WR, Topless R, Steer S, et al. (2010) The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthr Rheum In press.
16. Steck AK, Baschal EE, Jasinski JM, Boehm BO, Bottini N, et al. Rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. Genes Immun Suppl 1: S21-26.
17. Heward JM, Brand OJ, Barrett JC, Carr-Smith JD, Franklyn JA, Gough SC (2007) Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol Metab 92: 685-690.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
19. Marchini J, Howie B, Myers S, McVean G, Donnelly P (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39: 906-913.
20. Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15: 97-98.
21. Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121.